Metraipolis › archive › dc_dac26fc79675
Investigating subregional PD-L1 expression within primary tumors to predict clinical outcomes in advanced NSCLC patients who received ICB-based therapy — Europe PMC PMID:41179681
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41179681
- DOI
- 10.3389/fonc.2025.1497279
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T06:15:07.613Z
- SHA-256 of the archived text
e523d11545b379f626a80890c3bcbb6edfb14f79c189c7302adbb3f1ba88e5f0- Stable URL of this page
https://metraipolis.com/documento/dc_dac26fc79675
How to cite
Investigating subregional PD-L1 expression within primary tumors to predict clinical outcomes in advanced NSCLC patients who received ICB-based therapy — Europe PMC PMID:41179681 — Europe PMC (en), https://europepmc.org/article/MED/41179681 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dac26fc79675 (Metraipolis archive dc_dac26fc79675, sha256 e523d11545b379f626a80890c3bcbb6edfb14f79c189c7302adbb3f1ba88e5f0)
BibTeX
@misc{dcdac26fc79675,
title = {Investigating subregional PD-L1 expression within primary tumors to predict clinical outcomes in advanced NSCLC patients who received ICB-based therapy — Europe PMC PMID:41179681},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41179681},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dac26fc79675; sha256 e523d11545b379f626a80890c3bcbb6edfb14f79c189c7302adbb3f1ba88e5f0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41179681. Agents can read the archived copy with the MCP tool read_document.